[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 6 of about 6
1. Aversa do Souto A, Fonseca AL, Gadelha M, Donangelo I, Chimelli L, Domingues FS: Optic pathways tuberculoma mimicking glioma: case report. Surg Neurol; 2003 Oct;60(4):349-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Optic pathways tuberculoma mimicking glioma: case report.
  • The authors present a case of optic pathways tuberculoma with radiologic appearance simulating an optic pathways glioma.
  • Computed tomography (CT) and magnetic resonance imaging (MRI) showed an enhancing lesion in the optochiasmatic region extending to both optic nerves, with a mass in the right orbit, mimicking an optic pathways glioma.
  • The lesion was explored through a right pterional transylvian approach with opening of the optic canal and orbital roof, and a biopsy and an internal decompression were performed.
  • The patient improved after treatment with tuberculostatic drugs, but vision recovery could not be achieved.
  • CONCLUSIONS: Visual compromise in tuberculosis is associated with hydrocephalus, optical neuritis or tuberculomas involving the optic pathways.
  • Reviewing the literature on tuberculomas of the optochiasmatic area, we could not find any other case with such extensive involvement of the optic pathways that was radiologically suggestive of an infiltrating glioma.
  • [MeSH-major] Optic Nerve Diseases / diagnosis. Optic Nerve Diseases / surgery. Tuberculoma, Intracranial / diagnosis. Tuberculoma, Intracranial / surgery
  • [MeSH-minor] Adult. Diagnosis, Differential. Glioma / diagnosis. Humans. Magnetic Resonance Imaging. Male. Optic Nerve Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Glioma.
  • MedlinePlus Health Information. consumer health - Optic Nerve Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 14505863.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


2. Kortmann RD, Timmermann B, Taylor RE, Scarzello G, Plasswilm L, Paulsen F, Jeremic B, Gnekow AK, Dieckmann K, Kay S, Bamberg M: Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: Treatment modalities of radiation therapy. Strahlenther Onkol; 2003 Aug;179(8):509-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: Treatment modalities of radiation therapy.
  • Based on these experiences, future strategies in the management of childhood low-grade glioma are presented.
  • CONCLUSIONS: Radiation therapy is an effective treatment modality in children with low-grade glioma regarding tumor control and improvement and/or preservation of neurologic function or vision, respectively.
  • [MeSH-major] Brain Neoplasms / radiotherapy. Glioma / radiotherapy. Neurofibromatoses / radiotherapy. Optic Nerve Neoplasms / radiotherapy
  • [MeSH-minor] Adolescent. Adult. Age Factors. Astrocytoma / drug therapy. Astrocytoma / radiotherapy. Astrocytoma / surgery. Brachytherapy. Cerebellar Neoplasms / drug therapy. Cerebellar Neoplasms / radiotherapy. Cerebellar Neoplasms / surgery. Child. Child, Preschool. Clinical Trials as Topic. Combined Modality Therapy. Disease-Free Survival. Dose Fractionation. Dose-Response Relationship, Radiation. Follow-Up Studies. Humans. Hypothalamus. Medulloblastoma / drug therapy. Medulloblastoma / radiotherapy. Medulloblastoma / surgery. Optic Chiasm. Postoperative Care. Prognosis. Protons / therapeutic use. Radiotherapy Dosage. Radiotherapy Planning, Computer-Assisted. Radiotherapy, Conformal. Retrospective Studies. Survival Analysis. Time Factors. Vision, Ocular. Visual Pathways

  • Genetic Alliance. consumer health - Glioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • MedlinePlus Health Information. consumer health - Neurofibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 14509949.001).
  • [ISSN] 0179-7158
  • [Journal-full-title] Strahlentherapie und Onkologie : Organ der Deutschen RoĢˆntgengesellschaft ... [et al]
  • [ISO-abbreviation] Strahlenther Onkol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Protons
  • [Number-of-references] 77
  •  go-up   go-down


3. Airewele GE, Sigurdson AJ, Wiley KJ, Frieden BE, Caldarera LW, Riccardi VM, Lewis RA, Chintagumpala MM, Ater JL, Plon SE, Bondy ML: Neoplasms in neurofibromatosis 1 are related to gender but not to family history of cancer. Genet Epidemiol; 2001 Jan;20(1):75-86
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The risk of malignancies among persons with neurofibromatosis 1 (NF1) is higher than in the general population, but the excess risk has not been precisely estimated.
  • Therefore, we conducted a historical cohort study to determine cancer risk factors by contacting 138 Caucasian NF1 patients originally seen at Baylor College of Medicine (BCM) in Houston between 1978 and 1984.
  • Our results suggest that malignancy in the proband is not the result of a modifying gene that has a significant impact on general cancer risk.
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Female. Humans. Incidence. Infant. Infant, Newborn. Male. Optic Nerve Glioma / epidemiology. Optic Nerve Glioma / genetics. Reference Values. Risk Factors. Sex Factors. Texas / epidemiology

  • Genetic Alliance. consumer health - Neurofibromatosis.
  • MedlinePlus Health Information. consumer health - Cancer in Children.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2001 Wiley-Liss, Inc.
  • (PMID = 11119298.001).
  • [ISSN] 0741-0395
  • [Journal-full-title] Genetic epidemiology
  • [ISO-abbreviation] Genet. Epidemiol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R25 CA 57730
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


Advertisement
4. Lena G, Pech-Gourg G, Scavarda D, Klein O, Paz-Paredes A: [Optic nerve glioma in children]. Neurochirurgie; 2010 Apr-Jun;56(2-3):249-56
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Optic nerve glioma in children].
  • [Transliterated title] Gliome du nerf optique chez l'enfant.
  • Optic pathway gliomas are rare tumors accounting for 3-5% of brain tumors in children; 90% are observed in children.
  • Association with NF 1 is classical and the incidence of NF 1 in patients with optic pathway gliomas is estimated at 30-58%.
  • [MeSH-major] Glioma / epidemiology. Optic Nerve Neoplasms / epidemiology
  • [MeSH-minor] Adult. Antineoplastic Agents / therapeutic use. Blindness / etiology. Brain / pathology. Child. Child, Preschool. Exophthalmos / drug therapy. Exophthalmos / epidemiology. Exophthalmos / surgery. Female. Humans. Incidence. Infant. Magnetic Resonance Imaging. Male. Neurofibromatosis 1 / complications. Neurofibromatosis 1 / epidemiology. Neurofibromatosis 1 / pathology. Neurofibromatosis 1 / surgery. Orbit / pathology. Tomography, X-Ray Computed. Visual Acuity

  • Genetic Alliance. consumer health - Glioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Masson SAS. All rights reserved.
  • (PMID = 20303553.001).
  • [ISSN] 1773-0619
  • [Journal-full-title] Neuro-Chirurgie
  • [ISO-abbreviation] Neurochirurgie
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


5. Rudnik A, Zawadzki T, Wojtacha M, Bazowski P, Gamrot J, Galuszka-Ignasiak B, Duda I: Endoscopic transnasal transsphenoidal treatment of pathology of the sellar region. Minim Invasive Neurosurg; 2005 Apr;48(2):101-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • From October 2001 to the end of November 2002 in Department of Neurosurgery, Silesian University School of Medicine in Katowice 70 explorations of the sella turcica were executed using the endoscopic method.
  • In one case the diagnosis was craniopharyngioma, in 1 chordoma of the clivus, in one glioma of the optic nerve, in 1 the reason for an operation was an empty sella syndrome and in 3 cases the pathological diagnosis was an amorphous masses.
  • [MeSH-major] Endoscopy / methods. Nasal Cavity / surgery. Optic Nerve Glioma / surgery. Pituitary Diseases / surgery. Skull Base Neoplasms / surgery. Sphenoid Sinus / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Female. Humans. Length of Stay. Male. Middle Aged. Sella Turcica / pathology. Sella Turcica / surgery. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Pituitary Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15906205.001).
  • [ISSN] 0946-7211
  • [Journal-full-title] Minimally invasive neurosurgery : MIN
  • [ISO-abbreviation] Minim Invasive Neurosurg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


6. Drimmie FM, MacLennan AC, Nicoll JA, Simpson E, McNeill E, Donaldson MD: Gigantism due to growth hormone excess in a boy with optic glioma. Clin Endocrinol (Oxf); 2000 Oct;53(4):535-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gigantism due to growth hormone excess in a boy with optic glioma.
  • We report a case in which the endocrine abnormality is secondary to an optic glioma.
  • This boy appears likely to have neurofibromatosis type 1 (NF1) which raises the question of subtle GH excess in NF1 patients with tall stature.
  • [MeSH-major] Gigantism / etiology. Growth Hormone / blood. Optic Nerve Glioma / complications
  • [MeSH-minor] Adult. Child, Preschool. Gonadotropin-Releasing Hormone / analogs & derivatives. Goserelin / therapeutic use. Humans. Magnetic Resonance Imaging. Male. Neurofibromatosis 1 / complications. Neurofibromatosis 1 / diagnosis. Neurofibromatosis 1 / drug therapy. Octreotide / therapeutic use. Puberty, Precocious / complications. Puberty, Precocious / diagnosis. Puberty, Precocious / drug therapy. Somatostatin / analogs & derivatives

  • Genetic Alliance. consumer health - Gigantism.
  • Genetic Alliance. consumer health - Glioma.
  • Hazardous Substances Data Bank. GOSERELIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11012581.001).
  • [ISSN] 0300-0664
  • [Journal-full-title] Clinical endocrinology
  • [ISO-abbreviation] Clin. Endocrinol. (Oxf)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] ENGLAND
  • [Chemical-registry-number] 0F65R8P09N / Goserelin; 33515-09-2 / Gonadotropin-Releasing Hormone; 51110-01-1 / Somatostatin; 9002-72-6 / Growth Hormone; RWM8CCW8GP / Octreotide
  •  go-up   go-down






Advertisement